Drug Developement/Delivery
- Advancing CAR-T Therapy: In-situ PEGylation for Safer Treatment
- What is SNAC in oral semaglutide?
- 10 Potential Blockbuster Drug Approvals in 2023
- Bispecific Antibodies - Current Status and Prospects
- Cyclic Peptides: Current Status & Future Prospects
- Antibody–Oligonucleotide Conjugates (AOCs) in Clinical Trials
- Liposomes vs. Lipid Nanoparticles: Which Is Best for Drug Delivery?
- The Role of Four Lipid Components Of LNPs
- BCMA/CD3 Bispecific Antibodies for Multiple Myeloma (MM)
- Alzheimer's Disease Drug Development: Aducanumab, Lecanemab & Donanemab